Provention Bio Inc Investor Relations Material
Latest events
FDA Announcement
Provention Bio Inc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Provention Bio Inc
Access all reports
Provention Bio Inc. is a biopharmaceutical company focused on the development of therapies aimed at preventing and intercepting immune-mediated diseases, particularly in areas with significant unmet medical needs. The company specializes in immunology, working to create treatments that modulate the immune system to prevent the onset or progression of chronic diseases. Provention Bio collaborates with healthcare providers and research institutions to bring innovative therapeutic options to patients at risk of developing conditions with autoimmune components. The company is headquartered in Red Bank, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
PRVB
Country
🇺🇸 United States